发明名称 |
Treatment of diabetic patients with a drug eluting stent and adjunctive therapy |
摘要 |
Embodiments of the present invention include methods for the treatment, prevention, or amelioration of vascular disease in diabetic patients. The methods include both implantation of a stent including a first drug. Some embodiments include additional therapy, such as the co-administration of another drug. Some embodiments involve different stent selection for a diabetic patient compared to a non-diabetic patient. |
申请公布号 |
US9220759(B2) |
申请公布日期 |
2015.12.29 |
申请号 |
US201213403709 |
申请日期 |
2012.02.23 |
申请人 |
Abbott Cardiovascular Systems Inc. |
发明人 |
Hossainy Syed F. A.;Consigny Paul M. |
分类号 |
A61K9/00;A61K38/28;A61F2/82;A61K31/436;A61K31/426;A61K31/4365;A61K31/45;A61K31/4709;A61K31/506;A61K31/519;A61K31/553;A61K31/565;A61K31/573;A61K31/65;A61K45/06;A61K35/58;A61K38/58 |
主分类号 |
A61K9/00 |
代理机构 |
Squire Patton Boggs (US) LLP |
代理人 |
Squire Patton Boggs (US) LLP |
主权项 |
1. A method of treating, preventing, or ameliorating a vascular disease in a diabetic patient, the method comprising:
implanting a stent comprising a first drug in a vascular region of a diabetic patient; and administering a second drug to the diabetic patient via transdermal administration; wherein the first drug is an anti-inflammatory, an antiproliferative, an antineoplastic, an antimitotic, an antiplatelet, an anticoagulant, an antifibrin, an antithrombin, an antibiotic, an anti-allergic, an antioxidant substance, or any combination thereof; and wherein the second drug reduces platelet activation, reduces tissue factor activity, reduces thrombin activity, or any combination thereof. |
地址 |
Santa Clara CA US |